Abstract:<h3 class="Heading">Background</h3><p class="Para">As Genome-Wide Association Studies (GWAS) have been increasingly used with data from various populations, it has been observed that data from different populations reveal different sets of Single Nucleotide Polymorphisms (SNPs) that are associated with the same disease. Using Type II Diabetes (T2D) as a test case, we develop measures and methods to characterize the functional overlap of SNPs associated with the same disease across populations.</p><h3 class="Heading">Results</h3><p class="Para">We introduce the notion of an Overlap Matrix as a general means of characterizing the functional overlap between different SNP sets at different genomic and functional granularities. Using SNP-to-gene mapping, functional annotation databases, and functional association networks, we assess the degree of functional overlap across nine populations from Asian and European ethnic origins. We further assess the generalizability of the method by applying it to a dataset for another complex disease – Prostate Cancer. Our results show that more overlap is captured as more functional data is incorporated as we go through the pipeline, starting from SNPs and ending at network overlap analyses. We hypothesize that these observed differences in the functional mechanisms of T2D across populations can also explain the common use of different prescription drugs in different populations. We show that this hypothesis is concordant with the literature on the functional mechanisms of prescription drugs.</p><h3 class="Heading">Conclusion</h3><p class="Para">Our results show that although the etiology of a complex disease can be associated with distinct processes that are affected in different populations, network-based annotations can capture more functional overlap across populations. These results support the notion that it can be useful to take ethnicity into account in making personalized treatment decisions for complex diseases.</p>

The hazards of genotype imputation when mapping disease susceptibility variants

Feature Ranking of Type 1 Diabetes Susceptibility Genes Improves Prediction of Type 1 Diabetes

Alternative Methods for H1 Simulations in Genome Wide Association Studies

Analysis of Case-Control Association Studies: SNPs, Imputation and Haplotypes

Principles for the Post-Gwas Functional Characterisation of Risk Loci

Optimization Methods for Genotype Data Analysis in Epidemiological Studies

Prediction of type 1 diabetes using a genetic risk model in the Diabetes Autoimmunity Study in the Young.

1000 Genomes-based imputation identifies novel and refined associations for the Wellcome Trust Case Control Consortium phase 1 Data

MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes

Genome-wide association studies: theoretical and practical concerns

Impact of the inaccessible genome on genotype imputation and genome-wide association studies

Block-based Bayesian epistasis association mapping with application to WTCCC type 1 diabetes data

Discovery and Refinement of Genetic Loci Associated with Cardiometabolic Risk Using Dense Imputation Maps

Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps

Pitfall of genome-wide association studies: Sources of inconsistency in genotypes and their effects

Effect of genotype imputation on genome-enabled prediction of complex traits: an empirical study with mice data

Cross-population analysis for functional characterization of type II diabetes variants

Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity

Impact of genotyping errors on statistical power of association tests in genomic analyses: A case study.

Accurate cross-platform GWAS analysis via two-stage imputation

Transferability of type 2 diabetes implicated loci in multi-ethnic cohorts from Southeast Asia.